N-Acetylcysteine (NAC) Treatment
Sponsors
Medical University of South Carolina, Lahore General Hospital, University Hospital, Lille, Kurdistan University of Medical Sciences, Open Source Pharma Foundation
Conditions
Acute InfectionAcute Liver FailureAddictionAlcohol AbuseAlcoholic HepatitisDrug-Induced Liver InjuryParkinson's Disease (PD)Post Traumatic Stress Disorder (PTSD)
Phase 2
Clinical Trial for Alcohol Use Disorder and Post Traumatic Stress Disorder (PTSD)
CompletedNCT02966873
Start: 2016-10-01End: 2022-09-19Updated: 2025-02-06
Randomized, Placebo-Controlled Trial of N-acetylcysteine In Parkinson's Disease Patients: A Pilot Study
CompletedNCT07093944
Start: 2018-04-09End: 2021-12-22Updated: 2025-07-30
N-Acetylcysteine as Therapy for Transplantation- Associated Thrombotic Microangiopathy
Active, not recruitingNCT07279610
Start: 2024-05-01End: 2026-12-31Target: 44Updated: 2025-12-12
Phase 3
PROlonged Corticosteroid Treatment or N-ACetylcysteine for Severe Alcoholic Hepatitis
Not yet recruitingNCT06956482
Start: 2026-02-01End: 2027-01-01Target: 477Updated: 2026-01-20
A Trial of 2 Disease-Modifying Drugs (Metformin and N-acetylcysteine ) to Promote TB Lung Function Recovery
Not yet recruitingNCT07136987
Start: 2026-01-31End: 2031-07-31Target: 1104Updated: 2025-08-22